Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eagle Pharmaceuticals, Inc. (EGRX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eagle Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 827871.
Total stock buying since 2015: $1,656,721.
Total stock sales since 2015: $139,755,965.
Total stock option exercises since 2015: $3,724,969.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 101,864 | $1,833,118 | 9,360 | $46,238 |
| 2022 | 0 | $0 | 6,800 | $210,732 | 0 | $0 |
| 2021 | 0 | $0 | 0 | $0 | 38,221 | $325,379 |
| 2020 | 0 | $0 | 0 | $0 | 2,340 | $20,545 |
| 2019 | 0 | $0 | 349,280 | $18,948,539 | 4,680 | $18,906 |
| 2018 | 0 | $0 | 2,340 | $126,219 | 240,248 | $963,254 |
| 2017 | 28,066 | $1,599,991 | 432,419 | $36,229,368 | 70,645 | $1,077,360 |
| 2016 | 1,000 | $56,730 | 978,637 | $68,324,385 | 66,492 | $1,200,164 |
| 2015 | 0 | $0 | 239,227 | $14,083,604 | 9,980 | $73,123 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-11 | 0 | $0 | 21,619 | $299,308 | 0 | $0 |
| 2023-10 | 0 | $0 | 20,245 | $303,285 | 9,360 | $46,238 |
| 2023-05 | 0 | $0 | 60,000 | $1,230,525 | 0 | $0 |
| 2022-09 | 0 | $0 | 6,800 | $210,732 | 0 | $0 |
| 2021-04 | 0 | $0 | 0 | $0 | 38,221 | $325,379 |
| 2020-02 | 0 | $0 | 0 | $0 | 2,340 | $20,545 |
| 2019-10 | 0 | $0 | 77,588 | $4,800,751 | 0 | $0 |
| 2019-09 | 0 | $0 | 1,412 | $84,798 | 0 | $0 |
| 2019-05 | 0 | $0 | 159,223 | $9,045,972 | 0 | $0 |
| 2019-04 | 0 | $0 | 24,975 | $1,252,496 | 0 | $0 |
| 2019-03 | 0 | $0 | 24,428 | $1,249,736 | 4,680 | $18,906 |
| 2019-02 | 0 | $0 | 30,085 | $1,260,862 | 0 | $0 |
| 2019-01 | 0 | $0 | 31,569 | $1,253,924 | 0 | $0 |
| 2018-06 | 0 | $0 | 0 | $0 | 124,804 | $504,208 |
| 2018-03 | 0 | $0 | 2,340 | $126,219 | 115,444 | $459,046 |
| 2017-12 | 0 | $0 | 0 | $0 | 2,340 | $2,106 |
| 2017-08 | 20,750 | $1,021,413 | 0 | $0 | 0 | $0 |
| 2017-06 | 350 | $25,020 | 0 | $0 | 0 | $0 |
| 2017-05 | 455 | $36,768 | 0 | $0 | 0 | $0 |
| 2017-04 | 0 | $0 | 115,600 | $9,912,422 | 54,180 | $925,719 |
| 2017-03 | 6,511 | $516,790 | 251,705 | $20,771,838 | 14,125 | $149,535 |
| 2017-01 | 0 | $0 | 65,114 | $5,545,108 | 0 | $0 |
| 2016-12 | 0 | $0 | 70,505 | $5,344,885 | 60,505 | $1,156,008 |
| 2016-11 | 0 | $0 | 445,073 | $33,229,756 | 5,987 | $44,156 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-02 | Tarriff Scott (CEO) | Sale | 10,694 | 13.87 | 148,325 |
| 2023-11-01 | Tarriff Scott (CEO) | Sale | 10,925 | 13.82 | 150,983 |
| 2023-10-27 | Graves Michael (Director) | Option Ex | 9,360 | 4.94 | 46,238 |
| 2023-10-03 | Tarriff Scott (CEO) | Sale | 10,734 | 14.76 | 158,433 |
| 2023-10-02 | Tarriff Scott (CEO) | Sale | 9,511 | 15.23 | 144,852 |
| 2023-05-16 | Tarriff Scott (CEO) | Sale | 15,000 | 19.98 | 299,700 |
| 2023-05-15 | Tarriff Scott (CEO) | Sale | 15,000 | 21.29 | 319,350 |
| 2023-05-12 | Tarriff Scott (CEO) | Sale | 15,000 | 20.05 | 300,825 |
| 2023-05-11 | Tarriff Scott (CEO) | Sale | 15,000 | 20.71 | 310,650 |
| 2022-09-06 | Edlin Richard A. (Director) | Sale | 6,800 | 30.99 | 210,732 |
| 2021-04-08 | Ratoff Steven B (Director) | Option Ex | 7,020 | 7.33 | 51,435 |
| 2021-04-01 | Tarriff Scott (CEO) | Option Ex | 31,201 | 8.78 | 273,944 |
| 2020-02-28 | Ratoff Steven B (Director) | Option Ex | 2,340 | 8.78 | 20,545 |
| 2019-10-25 | Braunstein Douglas L | Sale | 15,437 | 63.57 | 981,299 |
| 2019-10-24 | Braunstein Douglas L | Sale | 1,494 | 62.52 | 93,412 |
| 2019-10-23 | Braunstein Douglas L | Sale | 200 | 62.58 | 12,516 |
| 2019-10-22 | Braunstein Douglas L | Sale | 6,567 | 62.68 | 411,619 |
| 2019-10-21 | Braunstein Douglas L | Sale | 3,849 | 62.56 | 240,789 |
| 2019-10-18 | Braunstein Douglas L | Sale | 1,600 | 62.61 | 100,174 |
| 2019-10-17 | Braunstein Douglas L | Sale | 13,842 | 62.58 | 866,190 |
| 2019-10-16 | Braunstein Douglas L | Sale | 102 | 62.50 | 6,375 |
| 2019-10-15 | Braunstein Douglas L | Sale | 3,909 | 62.63 | 244,836 |
| 2019-10-11 | Braunstein Douglas L | Sale | 16,300 | 60.39 | 984,422 |
| 2019-10-10 | Braunstein Douglas L | Sale | 7,829 | 60.16 | 471,000 |
| 2019-10-08 | Braunstein Douglas L | Sale | 1,558 | 60.03 | 93,520 |
| 2019-10-07 | Braunstein Douglas L | Sale | 4,901 | 60.11 | 294,599 |
| 2019-09-17 | Braunstein Douglas L | Sale | 100 | 60.00 | 6,000 |
| 2019-09-12 | Braunstein Douglas L | Sale | 200 | 60.07 | 12,014 |
| 2019-09-11 | Braunstein Douglas L | Sale | 1,112 | 60.06 | 66,784 |
| 2019-05-10 | Braunstein Douglas L | Sale | 100,000 | 56.14 | 5,614,000 |
| 2019-05-09 | Braunstein Douglas L | Sale | 59,223 | 57.95 | 3,431,972 |
| 2019-04-01 | Tarriff Scott (CEO) | Sale | 24,975 | 50.15 | 1,252,496 |
| 2019-03-05 | Flaum Sander A (Director) | Option Ex | 2,340 | 4.04 | 9,453 |
| 2019-03-04 | Ratoff Steven B (Director) | Option Ex | 2,340 | 4.04 | 9,453 |
| 2019-03-01 | Tarriff Scott (CEO) | Sale | 24,428 | 51.16 | 1,249,736 |
| 2019-02-01 | Tarriff Scott (CEO) | Sale | 30,085 | 41.91 | 1,260,862 |
| 2019-01-03 | Tarriff Scott (CEO) | Sale | 16,569 | 39.77 | 658,949 |
| 2019-01-02 | Tarriff Scott (CEO) | Sale | 15,000 | 39.66 | 594,975 |
| 2018-06-28 | Tarriff Scott (CEO) | Option Ex | 124,804 | 4.04 | 504,208 |
| 2018-03-30 | Tarriff Scott (CEO) | Option Ex | 113,104 | 4.04 | 456,940 |
| 2018-03-06 | Flaum Sander A (Director) | Sale | 2,340 | 53.94 | 126,219 |
| 2018-03-05 | Flaum Sander A (Director) | Option Ex | 2,340 | .90 | 2,106 |
| 2017-12-18 | Ratoff Steven B (Director) | Option Ex | 2,340 | .90 | 2,106 |
| 2017-08-16 | Meyers Pete A. (Chief Financial Officer) | Buy | 350 | 55.45 | 19,406 |
| 2017-08-09 | Braunstein Douglas L (Director) | Buy | 20,400 | 49.12 | 1,002,007 |
| 2017-06-12 | Meyers Pete A. (Chief Financial Officer) | Buy | 350 | 71.49 | 25,020 |
| 2017-05-19 | Pernock David (Pres. & Chief Comm. Officer) | Buy | 255 | 79.69 | 20,320 |
| 2017-05-16 | Pernock David (Pres. & Chief Comm. Officer) | Buy | 200 | 82.24 | 16,448 |
| 2017-04-25 | Schreiber Alain (10% Owner) | Sale | 54,180 | 88.72 | 4,806,578 |
| 2017-04-25 | Schreiber Alain (10% Owner) | Option Ex | 54,180 | 17.09 | 925,719 |
| 2017-04-03 | Schreiber Alain (10% Owner) | Sale | 61,420 | 83.13 | 5,105,844 |
| 2017-03-31 | Schreiber Alain (10% Owner) | Sale | 23,689 | 83.02 | 1,966,660 |
| 2017-03-30 | Schreiber Alain (10% Owner) | Sale | 6,223 | 83.00 | 516,509 |
| 2017-03-29 | Schreiber Alain (10% Owner) | Sale | 60,855 | 83.01 | 5,051,573 |
| 2017-03-28 | Schreiber Alain (10% Owner) | Sale | 6,182 | 83.02 | 513,229 |
| 2017-03-27 | Schreiber Alain (10% Owner) | Sale | 39,431 | 83.00 | 3,272,773 |
| 2017-03-23 | Krill Steven L. (EVP & Chief Scientific Officer) | Sale | 7,025 | 82.06 | 576,492 |
| 2017-03-23 | Krill Steven L. (EVP & Chief Scientific Officer) | Option Ex | 7,025 | 12.65 | 88,866 |
| 2017-03-23 | Schreiber Alain (10% Owner) | Sale | 700 | 83.01 | 58,107 |
| 2017-03-22 | Edlin Richard A. (Director) | Buy | 6,000 | 79.44 | 476,640 |
| 2017-03-22 | Krill Steven L. (EVP & Chief Scientific Officer) | Sale | 7,100 | 80.09 | 568,639 |
| 2017-03-22 | Krill Steven L. (EVP & Chief Scientific Officer) | Option Ex | 7,100 | 8.54 | 60,669 |
| 2017-03-21 | Pernock David (Pres. & Chief Comm. Officer) | Buy | 61 | 83.98 | 5,122 |
| 2017-03-21 | Schreiber Alain (10% Owner) | Sale | 500 | 83.10 | 41,550 |
| 2017-03-20 | Schreiber Alain (10% Owner) | Sale | 51,883 | 82.10 | 4,259,594 |
| 2017-03-17 | Schreiber Alain (10% Owner) | Sale | 38,997 | 82.01 | 3,198,143 |
| 2017-03-16 | Schreiber Alain (10% Owner) | Sale | 9,120 | 82.08 | 748,569 |
| 2017-03-09 | Pernock David (Pres. & Chief Comm. Officer) | Buy | 450 | 77.84 | 35,028 |
| 2017-01-04 | Schreiber Alain (10% Owner) | Sale | 65,114 | 85.16 | 5,545,108 |
| 2016-12-23 | Krill Steven L. (EVP & Chief Scientific Officer) | Sale | 5,127 | 78.61 | 403,018 |
| 2016-12-23 | Krill Steven L. (EVP & Chief Scientific Officer) | Option Ex | 5,127 | 46.09 | 236,303 |
| 2016-12-22 | Krill Steven L. (EVP & Chief Scientific Officer) | Sale | 5,126 | 76.78 | 393,569 |
| 2016-12-22 | Krill Steven L. (EVP & Chief Scientific Officer) | Option Ex | 5,126 | 46.09 | 236,257 |
| 2016-12-21 | Krill Steven L. (EVP & Chief Scientific Officer) | Sale | 10,252 | 77.17 | 791,198 |
| 2016-12-21 | Krill Steven L. (EVP & Chief Scientific Officer) | Option Ex | 10,252 | 29.36 | 300,998 |
| 2016-12-20 | Krill Steven L. (EVP & Chief Scientific Officer) | Sale | 10,000 | 76.69 | 766,880 |
| 2016-12-20 | Krill Steven L. (EVP & Chief Scientific Officer) | Option Ex | 10,000 | 12.63 | 126,300 |
| 2016-12-19 | Krill Steven L. (EVP & Chief Scientific Officer) | Sale | 10,000 | 75.61 | 756,070 |
| 2016-12-19 | Krill Steven L. (EVP & Chief Scientific Officer) | Option Ex | 10,000 | 12.65 | 126,500 |
| 2016-12-15 | Krill Steven L. (EVP & Chief Scientific Officer) | Sale | 10,000 | 74.79 | 747,900 |
| 2016-12-15 | Krill Steven L. (EVP & Chief Scientific Officer) | Option Ex | 10,000 | 8.54 | 85,450 |
| 2016-12-13 | Krill Steven L. (EVP & Chief Scientific Officer) | Sale | 10,000 | 73.62 | 736,160 |
| 2016-12-13 | Krill Steven L. (EVP & Chief Scientific Officer) | Option Ex | 10,000 | 4.42 | 44,200 |
| 2016-12-13 | Ratoff Steven B (Director) | Sale | 8,700 | 75.00 | 652,500 |
| 2016-12-12 | Ratoff Steven B (Director) | Sale | 1,300 | 75.07 | 97,590 |
| 2016-11-30 | Krill Steven L. (EVP & Chief Scientific Officer) | Sale | 5,787 | 80.00 | 462,960 |
| 2016-11-30 | Krill Steven L. (EVP & Chief Scientific Officer) | Option Ex | 5,787 | 7.33 | 42,401 |
| 2016-11-28 | Flaum Sander A (Director) | Sale | 5,000 | 78.66 | 393,300 |
| 2016-11-23 | Krill Steven L. (EVP & Chief Scientific Officer) | Sale | 200 | 80.00 | 16,000 |
| 2016-11-23 | Krill Steven L. (EVP & Chief Scientific Officer) | Option Ex | 200 | 8.78 | 1,755 |
| 2016-11-11 | Schreiber Alain (10% Owner) | Sale | 15,551 | 85.00 | 1,321,835 |
| 2016-11-10 | Schreiber Alain (10% Owner) | Sale | 18,935 | 85.70 | 1,622,767 |
| 2016-11-09 | Schreiber Alain (10% Owner) | Sale | 148,800 | 77.81 | 11,578,574 |
| 2016-11-07 | Schreiber Alain (10% Owner) | Sale | 5,030 | 75.39 | 379,211 |
| 2016-11-04 | Schreiber Alain (10% Owner) | Sale | 46,170 | 75.00 | 3,462,750 |
| 2016-11-02 | Schreiber Alain (10% Owner) | Sale | 199,600 | 70.10 | 13,992,359 |
| 2016-09-30 | Schreiber Alain (10% Owner) | Sale | 22,100 | 70.06 | 1,548,326 |
| 2016-09-29 | Schreiber Alain (10% Owner) | Sale | 77,900 | 70.04 | 5,456,116 |
| 2016-09-21 | Schreiber Alain (10% Owner) | Sale | 99,795 | 66.43 | 6,629,681 |
| 2016-09-08 | Schreiber Alain (10% Owner) | Sale | 34,086 | 62.33 | 2,124,580 |
| 2016-09-07 | Schreiber Alain (10% Owner) | Sale | 11,442 | 62.26 | 712,378 |
| 2016-09-06 | Schreiber Alain (10% Owner) | Sale | 25,397 | 62.84 | 1,595,947 |
| 2016-08-24 | Schreiber Alain (10% Owner) | Sale | 11,605 | 62.78 | 728,561 |
| 2016-08-23 | Schreiber Alain (10% Owner) | Sale | 17,265 | 63.13 | 1,089,887 |
| 2016-08-17 | Schreiber Alain (10% Owner) | Sale | 14,696 | 61.01 | 896,602 |
| 2016-08-16 | Schreiber Alain (10% Owner) | Sale | 60,150 | 61.22 | 3,682,142 |
| 2016-08-15 | Schreiber Alain (10% Owner) | Sale | 24,949 | 60.80 | 1,517,023 |
| 2016-04-01 | Tarriff Scott (President and CEO) | Sale | 30,765 | 40.63 | 1,249,981 |
| 2016-03-15 | Graves Michael (Director) | Buy | 1,000 | 56.73 | 56,730 |
| 2016-02-01 | Tarriff Scott (President and CEO) | Sale | 18,360 | 68.76 | 1,262,433 |
| 2016-01-04 | Tarriff Scott (President and CEO) | Sale | 14,549 | 86.33 | 1,256,087 |
| 2015-12-22 | Flaum Sander A (Director) | Sale | 3,225 | 93.75 | 302,359 |
| 2015-12-01 | Tarriff Scott (President and CEO) | Sale | 14,050 | 89.20 | 1,253,316 |
| 2015-11-02 | Tarriff Scott (President and CEO) | Sale | 19,339 | 64.78 | 1,252,877 |
| 2015-10-01 | Tarriff Scott (President and CEO) | Sale | 17,878 | 71.02 | 1,269,606 |
| 2015-09-01 | Tarriff Scott (President and CEO) | Sale | 16,245 | 76.50 | 1,242,823 |
| 2015-08-03 | Tarriff Scott (President and CEO) | Sale | 13,000 | 95.88 | 1,246,375 |
| 2015-07-01 | Tarriff Scott (President and CEO) | Sale | 15,710 | 79.58 | 1,250,280 |
| 2015-06-16 | Krill Steven L. (Chief Scientific Officer) | Sale | 9,980 | 81.60 | 814,368 |
| 2015-06-16 | Krill Steven L. (Chief Scientific Officer) | Option Ex | 9,980 | 7.33 | 73,123 |
| 2015-03-20 | Tarriff Scott (President and CEO) | Sale | 120,000 | 42.00 | 5,040,000 |
| 2015-03-20 | Flaum Sander A (Director) | Sale | 9,800 | 42.00 | 411,600 |
Insider trading activities including stock purchases, stock sales, and option exercises of EGRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eagle Pharmaceuticals, Inc. (symbol EGRX, CIK number 827871) see the Securities and Exchange Commission (SEC) website.